The once high-flying Danish drugmaker has struggled to fend off rivals in the weight-loss industry and faces lower prices for its medicines under a deal with President Trump.The once high-flying Danish drugmaker has struggled to fend off rivals in the weight-loss industry and faces lower prices for its medicines under a deal with President Trump. Drugs (Pharmaceuticals), Prices (Fares, Fees and Rates), GLP-1 RAs (Drug), Stocks and Bonds, Company Reports, Novo Nordisk A/S Read More
Novo Nordisk Warns of First Sales Drop Since Start of Ozempic
